Oxycodone and Prostatitis - chronic - a phase IV clinical study of FDA data
Summary:
We study 162,671 people who take Oxycodone (oxycodone hydrochloride) or have Prostatitis - chronic. No report of Prostatitis - chronic is found in people who take Oxycodone.
The phase IV clinical study is created by eHealthMe based on reports from the FDA, and is updated regularly.
What is Oxycodone?
Oxycodone has active ingredients of oxycodone hydrochloride. It is often used in pain. eHealthMe is studying from 162,592 Oxycodone users. Check the latest studies of Oxycodone.
What is Prostatitis - Chronic?
Prostatitis - chronic: no further information found. Check the latest studies of Prostatitis - chronic.
No report is found.
Do you take Oxycodone and have Prostatitis - chronic?
- Check whether Prostatitis - chronic is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Oxycodone:
- Oxycodone (162,592 reports)
Prostatitis - chronic treatments and more:
- Prostatitis - chronic (79 reports)
How severe was Prostatitis - chronic and when was it recovered:
Expand to all the drugs that have ingredients of oxycodone hydrochloride:
Browse all side effects of Oxycodone:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Prostatitis - chronic:
Browse all the conditions that are associated with Prostatitis - chronic:
How the study uses the data?
The study uses data from the FDA. It is based on oxycodone hydrochloride (the active ingredients of Oxycodone) and Oxycodone (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Ayvakit cause Blood Bilirubin Increased? - 6 seconds ago
- Could Avapro cause Surgery? - 8 seconds ago
- Could Axitinib cause Blood Bilirubin Increased? - 10 seconds ago
- Drug interactions of Acarbose and Folic Acid - 15 seconds ago
- Could Belsomra cause Sleep Paralysis? - 19 seconds ago
- Could Itraconazole cause High Blood Pressure? - 30 seconds ago
- Could Augmentin cause Haemangioma? - 33 seconds ago
- Could Augmentin cause Exanthem? - 36 seconds ago
- Drug interactions of Cefazolin and Atenolol - 41 seconds ago
- Endometrial Cancer and Disease Recurrence - 42 seconds ago